EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®)
EGFR 免疫组织化学作为鳞状 NSCLC 抗体治疗的生物标志物 - 德国病理学质量保证倡议 (QuIP®) 首次环行试验的经验
期刊:Pathology Research and Practice
影响因子:2.9
doi:10.1016/j.prp.2017.09.021
Iver Petersen, Manfred Dietel, Wolf J Geilenkeuser, Masoud Mireskandari, Wilko Weichert, Katja Steiger, Andreas H Scheel, Reinhard Büttner, Peter Schirmacher, Arne Warth, Felix Lasitschka, Hans-Ulrich Schildhaus, Thomas Kirchner, Simone Reu, Hans Kreipe, Florian Länger, Markus Tiemann, Christoph Sch